Risedronate for the prevention and treatment of postmenopausal osteoporosis: Results from recent clinical trials

被引：0
作者：
Watts, NB
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] Emory Clin Inc, Osteoporosis Program, Atlanta, GA 30322 USA
[3] Emory Clin Inc, Bone Hlth Program, Atlanta, GA 30322 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2001年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 22
页数：6
相关论文
共 21 条
  • [1] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
    Adachi, JD
    Bensen, WG
    Brown, J
    Hanley, D
    Hodsman, A
    Josse, R
    Kendler, DL
    Lentle, B
    Olszynski, W
    SteMarie, LG
    Tenenhouse, A
    Chines, AA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) : 382 - 387
  • [2] Azuma Y, 1998, J PHARMACOL EXP THER, V286, P128
  • [3] Berenson JR, 1999, ANNU REV MED, V50, P237
  • [4] Current use of bisphosphonates in oncology
    Body, JJ
    Bartl, R
    Burckhardt, P
    Delmas, PD
    Diel, IJ
    Fleisch, H
    Kanis, JA
    Kyle, RA
    Mundy, GR
    Paterson, AHG
    Rubens, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3890 - 3899
  • [5] The pathogenesis of osteoporosis
    Eriksen, EF
    Langdahl, BL
    [J]. HORMONE RESEARCH, 1997, 48 : 78 - 82
  • [6] Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial
    Fogelman, I
    Ribot, C
    Smith, R
    Ethgen, D
    Sod, E
    Reginster, JY
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) : 1895 - 1900
  • [7] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial
    Harris, ST
    Watts, NB
    Genant, HK
    McKeever, CD
    Hangartner, T
    Keller, M
    Chesnut, CH
    Brown, J
    Eriksen, EF
    Hoseyni, MS
    Axelrod, DW
    Miller, PD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14): : 1344 - 1352
  • [8] Etidronate (EHDP) inhibits osteoclastic-bone resorption, promotes apoptosis and disrupts actin rings in isolate-mature osteoclasts
    Hiroi-Furuya, E
    Kameda, T
    Hiura, K
    Mano, H
    Miyazawa, K
    Nakamaru, Y
    Watanabe-Mano, M
    Okuda, N
    Shimada, J
    Yamamoto, Y
    Hakeda, Y
    Kumegawa, M
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1999, 64 (03) : 219 - 223
  • [9] Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta
    Hughes, DE
    Dai, AH
    Tiffee, JC
    Li, HH
    Mundy, GR
    Boyce, BF
    [J]. NATURE MEDICINE, 1996, 2 (10) : 1132 - 1136
  • [10] EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS
    LIBERMAN, UA
    WEISS, SR
    BROLL, J
    MINNE, HW
    QUAN, H
    BELL, NH
    RODRIGUEZPORTALES, J
    DOWNS, RW
    DEQUEKER, J
    FAVUS, M
    SEEMAN, E
    RECKER, RR
    CAPIZZI, T
    SANTORA, AC
    LOMBARDI, A
    SHAH, RV
    HIRSCH, LJ
    KARPF, DB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) : 1437 - 1443
123